1 de julio de 2025 Cardiometabolic diseases

Hyperlipidaemia: when and how to start statin therapy

During the last decades, the prevalence of some non-communicable diseases, such as hyperlipidaemia, has been increasing globally. A recent meta-analysis conducted in the Middle East found a pooled prevalence of 32.09% for elevated low-density lipoprotein cholesterol (LDL-C).1 Increased blood levels of LDL-C, classified as hyperlipidaemia, is a well-established causal risk factor for atherosclerotic cardiovascular disease (ASCVD)

Read more
30 de julio de 2025 Cardiometabolic diseases

The ticking clock of metabolic syndrome: why early detection matters

Metabolic syndrome is a complex set of interconnected physiological, biochemical, and metabolic factors that contribute to the development of several chronic conditions, such as cardiovascular disease or type 2 diabetes.

Read more